Dengue vaccine study for adults aged 45 to 79
Part of Infections clinical trials.
This study tests a dengue vaccine (TDV) in adults aged 45 to 79. It aims to see if the vaccine is safe and effective, even for people with common health conditions like diabetes or high blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 45 and 79 years old.
- You are in good health, OR you have diabetes, high blood pressure, or chronic kidney disease that has been stable (no medication changes) for the past 3 months.
- You have never received a dengue vaccine before.
- You do not have a weakened immune system (from HIV, hepatitis, cancer treatment, or long-term high-dose steroids).
- You have not had other vaccines in the last 14 to 28 days (depending on type).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests two doses of a dengue vaccine in healthy infants and toddlers aged 6 to 21 months. It aims to see if the vaccine is safe and helps protect against dengue fever.
This study tests if a dengue vaccine (TDV) can reduce hospital stays for dengue. It follows children and teens in areas where dengue vaccination is planned.
This trial tests a new dengue vaccine in adults aged 40 to 79 to see if it can protect them from dengue fever. If you are generally healthy and willing to follow the study schedule, you may be able to join.
This study looks at how the dengue vaccine works in people with and without past exposure to dengue or similar viruses like yellow fever or Zika. Volunteers receiving the dengue vaccine will give blood samples to help researchers understand the immune response.
This trial tests an experimental dengue vaccine in healthy children and teens to see if it can prevent dengue. It may help protect your child from this mosquito-borne illness.
This study tests if a two-dose dengue vaccine works better than the standard single dose for children and teens who have never had dengue. It also checks if the vaccine works the same when made at a different factory.
Hear when a new Dengue Fever trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.